Skip to main content
Economics

Interventions to mitigate post-infection morbidity: Management insights from simple models.

| Source: Proceedings of the National Academy of Sciences of the United States of America

A variety of pathogens that cause acute disease can also affect their host long after recovery. These post-infection effects lead to elevated costs for individuals and societies, which can be mitigated by large-scale interventions. Here, we examine the management of post-infection morbidity with mathematical models. First, we show that long-term usage of nonpharmaceutical interventions can reduce post-acute burden. Second, to investigate how post-infection effects affect optimal vaccination cove

A variety of pathogens that cause acute disease can also affect their host long after recovery. These post-infection effects lead to elevated costs for individuals and societies, which can be mitigated by large-scale interventions. Here, we examine the management of post-infection morbidity with mathematical models. First, we show that long-term usage of nonpharmaceutical interventions can reduce post-acute burden. Second, to investigate how post-infection effects affect optimal vaccination coverage, we generalize and expand on classic epidemiological-economic models. We include post-infection costs, and consider the cost of vaccination as a general increasing function of coverage. If there is some sub-elimination coverage that locally minimizes costs (beyond elimination), we show that the decision of whether to vaccinate or not is independent of the transmission rate (however elimination does depend on this). Echoing existing theoretical results with exponentially increasing costs, we find that if vaccination costs either only accelerate or only decelerate with increased coverage, there is a unique, transmission-independent interior level of vaccination coverage (nonzero and sub-elimination) that locally minimizes or maximizes societal costs, respectively. In all settings, we show that post-infection effects can substantially shift societal incentives toward elimination. Furthermore, when costs of vaccination change concavity, the optimal coverage level is very sensitive to post-infection costs: a small increase can shift optimal coverage from none (or low coverage) to elimination. Our findings demonstrate that post-infection morbidity has important implications for policy and management, and that there is an urgent need to quantify costs of post-infection effects and of large-scale vaccine deployment.

Read the original source →

Related Stories

Economics

A signal convention in natural chimpanzee communication.

Human language relies on conventional signals that are arbitrary, stable, and socially transmitted. Whether other animals exhibit meaning-based communicative conventions is virtually unknown. Using a quasi-experimental design, we investigated this in chimpanzee unvoiced calls (UCs), such as acoustic raspberries, known to show usage variation. We collected audio and contextual data in 91 chimpanzees (0 to 55 y), across eight wild and captive groups that differed in the presence or absence of adul

Continue reading
Economics

Core effectors of the Fusarium pan-effectome contribute to host specificity.

Fusarium fungi cause economically important diseases of cereal crops, including Fusarium head blight, ear blight, and root rot. Central to these interactions are secreted effector proteins that manipulate host biology to promote infection. In turn, plants have evolved to recognize effector activity to activate immune responses and restrict disease. Despite their importance, the diversity, conservation, and evolution of Fusarium effectors remain poorly understood. Here, we present the Fusarium sa

Continue reading
Economics

Comprehensive mapping of essential-gene interactions in M. tuberculosis.

Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the world's deadliest pathogen 1 . Despite intensive study, many of its genes remain uncharacterized, which limits the insight that can be gained into tuberculosis biology and constrains drug development. Genetic interaction (GI) mapping is a powerful strategy to define functional relationships between genes by quantifying how the phenotypic effects of combined perturbations deviate from expectations based on single-gene pe

Continue reading
Economics

A glycan superbinder reveals polysialylated-CD56 as a precision biomarker for pancreatic cancer.

Pancreatic cancer remains one of the most lethal malignancies, largely due to the lack of reliable biomarkers for early detection. Aberrant glycosylation presents a promising source of diagnostic signatures, yet polysialic acid (polySia), a distinctive glycan, has remained underexplored, primarily owing to limitations in detection methods and recognition tools. Here, we report the development of a polySia "superbinder," a nanoscale molecularly imprinted polymer (nanoMIP) that exhibits superior s

Continue reading
Economics

Structural basis of glycoprotein recognition by the human folding sensor UDP-glucose:glycoprotein glucosyltransferase.

UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1) plays a central role in quality control of glycoprotein folding within the early secretory pathway, yet the molecular basis of UGGT1 substrate recognition remains poorly understood. Here, we report cryo-EM structures of human full-length multidomain UGGT1. Monomeric UGGT1 structures reveal two conformational states corresponding to "open" and "closed" architectures. Three-dimensional variability and molecular dynamics simulations suggest the

Continue reading